StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
86
This year
1
Publishing Date
2022 - 09 - 15
2
2022 - 07 - 13
1
2022 - 06 - 29
1
2022 - 06 - 10
1
2022 - 06 - 06
2
2022 - 05 - 16
1
2022 - 04 - 27
1
2022 - 04 - 07
1
2022 - 03 - 15
1
2022 - 02 - 23
1
2022 - 02 - 16
2
2022 - 01 - 27
1
2022 - 01 - 06
1
2021 - 12 - 17
1
2021 - 12 - 15
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 12 - 12
1
2021 - 12 - 02
2
2021 - 12 - 01
1
2021 - 11 - 24
1
2021 - 11 - 05
1
2021 - 10 - 29
1
2021 - 10 - 07
1
2021 - 09 - 20
1
2021 - 09 - 14
1
2021 - 09 - 08
1
2021 - 09 - 07
1
2021 - 08 - 12
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
2021 - 06 - 15
1
2021 - 06 - 14
1
2021 - 06 - 11
1
2021 - 06 - 04
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 06
1
2021 - 05 - 04
2
2021 - 04 - 15
1
2021 - 04 - 08
1
2021 - 03 - 23
1
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 16
1
2021 - 03 - 08
1
2021 - 03 - 02
3
2021 - 02 - 24
1
2021 - 02 - 19
1
2021 - 02 - 17
1
2021 - 02 - 05
1
2021 - 02 - 04
1
2021 - 01 - 27
1
2021 - 01 - 07
1
2021 - 01 - 05
1
2020 - 12 - 15
1
2020 - 12 - 07
1
2020 - 12 - 06
2
2020 - 12 - 02
1
Sector
Commercial services
1
Finance
1
Health technology
86
Manufacturing
2
N/a
2
Process industries
1
Professional, scientific, and technical services
3
Technology services
1
Tags
Acquire
1
Acquisition
1
Active
1
Anemia
4
Application
1
Authorization
1
Authorized
1
Awards
1
Biotech
2
Biotech-bay
6
Biotech-beach
1
Blood
3
Brazil
1
Cel
3
Cell
2
Children
2
Chmp
1
Clinical-trials-phase-ii
1
Collaboration
1
Commercialization
1
Companies
2
Conference
4
Designation
2
Disease
33
Drug
2
Earnings
8
Europe
5
Events
2
Fda
2
Financial
3
Financial results
9
Gbt601
2
Genetown
2
Global
6
Grant
12
Granted
11
Grants
2
Health
4
Iot
2
Market
6
Milestone
4
Money
2
N/a
53
Offering
2
Order
2
Oxbryta
11
People
2
Pharmaceutical
3
Phase 3
2
Positive
5
Potential
2
Program
2
Rare
2
Report
4
Research
4
Results
17
Technology
3
Therapeutics
4
Treatment
10
Trial
2
Entities
Abbott laboratories
2
Abbvie inc.
2
Adverum biotechnologies, inc.
2
Agios pharmaceuticals, inc.
2
Aligos therapeutics, inc.
4
Alnylam pharmaceuticals, inc.
2
Arrival
1
Arvinas, inc.
1
Astrazeneca plc
1
Beam therapeutics inc.
3
Biohaven pharmaceutical holding company ltd.
2
Biolinerx ltd.
1
Biontech se
3
Bluebird bio, inc.
1
Boston scientific corporation
2
Caredx, inc.
1
Cohbar, inc.
1
Danaher corporation
2
Editas medicine, inc.
1
Eiger biopharmaceuticals, inc.
2
Eli lilly and company
3
Emmaus life sciences, inc.
3
Evo payments, inc.
1
Forma therapeutics holdings, inc.
1
Gilead sciences, inc.
2
Glaukos corporation
2
Glaxosmithkline plc
3
Global blood therapeutics, inc.
86
Global payments inc.
1
Gritstone oncology, inc.
2
Haleon plc
1
Incyte corporation
5
Johnson & johnson
4
Karyopharm therapeutics inc.
2
Mallinckrodt plc
1
Morgan stanley
1
Novartis ag
3
Novo nordisk a/s
2
Passage bio, inc.
2
Pfizer, inc.
6
Precision biosciences, inc.
1
Regeneron pharmaceuticals, inc.
2
Resolute forest products inc.
1
Sangamo therapeutics, inc.
1
Sanofi
8
Supernus pharmaceuticals, inc.
1
Syros pharmaceuticals, inc.
6
Takeda pharmaceutical company limited
3
Tarsus pharmaceuticals, inc.
1
Vertex pharmaceuticals incorporated
1
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Nasdaq
86
Nyse
13
Crawled Date
2022 - 09 - 15
2
2022 - 07 - 13
1
2022 - 06 - 29
1
2022 - 06 - 10
1
2022 - 06 - 06
2
2022 - 05 - 16
1
2022 - 04 - 27
1
2022 - 04 - 07
1
2022 - 03 - 15
1
2022 - 02 - 23
1
2022 - 02 - 16
2
2022 - 01 - 27
1
2022 - 01 - 06
1
2021 - 12 - 17
1
2021 - 12 - 15
1
2021 - 12 - 14
1
2021 - 12 - 13
1
2021 - 12 - 12
1
2021 - 12 - 02
2
2021 - 12 - 01
1
2021 - 11 - 24
1
2021 - 11 - 05
1
2021 - 10 - 29
1
2021 - 10 - 07
1
2021 - 09 - 20
1
2021 - 09 - 14
1
2021 - 09 - 08
1
2021 - 09 - 07
1
2021 - 08 - 12
1
2021 - 08 - 06
1
2021 - 08 - 05
1
2021 - 07 - 20
1
2021 - 06 - 15
1
2021 - 06 - 14
1
2021 - 06 - 11
1
2021 - 06 - 04
1
2021 - 05 - 12
1
2021 - 05 - 07
1
2021 - 05 - 06
1
2021 - 05 - 04
2
2021 - 04 - 15
1
2021 - 04 - 08
1
2021 - 03 - 23
1
2021 - 03 - 18
1
2021 - 03 - 17
1
2021 - 03 - 16
1
2021 - 03 - 08
1
2021 - 03 - 02
3
2021 - 02 - 24
1
2021 - 02 - 19
1
2021 - 02 - 17
1
2021 - 02 - 05
1
2021 - 02 - 04
1
2021 - 01 - 27
1
2021 - 01 - 07
1
2021 - 01 - 05
1
2020 - 12 - 15
1
2020 - 12 - 07
1
2020 - 12 - 06
2
2020 - 12 - 02
1
Crawled Time
01:00
1
04:00
1
07:00
1
08:00
3
09:00
2
11:00
1
12:00
10
12:01
1
12:02
1
12:15
3
12:20
1
12:30
2
13:00
7
13:01
2
13:03
7
13:15
3
13:20
2
13:30
4
14:00
4
14:03
1
14:15
1
14:20
2
15:00
4
15:01
2
15:15
1
15:30
1
16:00
3
16:20
1
17:00
1
19:00
1
20:20
1
21:00
3
22:00
6
23:00
2
Source
www.biospace.com
29
www.globenewswire.com
46
www.prnewswire.com
11
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
GBT
save search
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
Published:
2024-02-13
(Crawled : 13:00)
- globenewswire.com
CWBR
|
$0.9003
-11.88%
360
|
Health Technology
|
3.99%
|
O:
6.09%
H:
0.0%
C:
-17.23%
CDNA
|
$8.32
3.1%
3.0%
500K
|
Health Technology
|
-8.38%
|
O:
-7.39%
H:
2.74%
C:
-5.24%
ALGS
|
$0.735
-7.33%
-7.9%
140K
|
Health Technology
|
10.29%
|
O:
1.47%
H:
1.45%
C:
-7.54%
therapeutics
Sickle Cell Disease Clinical Trial Pipeline Accelerates as 40+ Pharma Companies Rigorously Developing Drugs for the Market Entry
Published:
2023-07-11
(Crawled : 21:00)
- prnewswire.com
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
1521.71%
|
O:
1.57%
H:
19.67%
C:
9.97%
BLUE
|
$1.02
7.03%
6.11%
8.2M
|
Health Technology
|
-71.9%
|
O:
2.2%
H:
0.27%
C:
-1.62%
BLRX
|
$0.6564
2.55%
2.48%
190K
|
Health Technology
|
-61.18%
|
O:
0.0%
H:
2.94%
C:
-0.59%
pharma
disease
companies
pipeline
cell
trial
market
Sickle Cell Disease Market to Observe Impressive Growth, Predicts DelveInsight | Key Companies Active in the Domain - Sanofi, Novartis, Vertex, CRISPR, Vifor, Pfizer, GlaxoSmithKline, Alexion, Global Blood
Published:
2023-05-22
(Crawled : 15:00)
- prnewswire.com
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
15.39%
|
O:
0.69%
H:
0.56%
C:
-1.19%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-15.45%
|
O:
-0.75%
H:
0.0%
C:
0.0%
EDIT
|
$5.5
-0.9%
-0.91%
2.3M
|
Health Technology
|
-41.09%
|
O:
-0.97%
H:
4.98%
C:
4.44%
BEAM
|
$23.9
-1.69%
-1.72%
4.5M
|
Health Technology
|
-30.8%
|
O:
0.2%
H:
2.51%
C:
1.56%
AGIO
|
$29.52
0.31%
0.3%
750K
|
Health Technology
|
13.14%
|
O:
0.38%
H:
2.48%
C:
1.87%
disease
companies
active
cell
blood
global
market
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
Published:
2023-04-24
(Crawled : 13:00)
- biospace.com/
TARS
|
$32.405
-1.36%
-1.37%
630K
|
Health Technology
|
116.99%
|
O:
-1.47%
H:
0.75%
C:
-0.75%
financial
ElevateBio Appoints Heidi L. Wagner, J.D., as Global Head of Government Affairs
Published:
2023-03-07
(Crawled : 14:00)
- biospace.com/
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
Email alert
Add to watchlist
global
PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE
Published:
2023-01-31
(Crawled : 13:00)
- biospace.com/
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
14.64%
|
O:
2.04%
H:
0.0%
C:
-3.67%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-40.3%
|
O:
-1.26%
H:
2.97%
C:
2.7%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
13.18%
|
O:
0.85%
H:
0.31%
C:
-0.45%
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
109.85%
|
O:
-0.48%
H:
4.49%
C:
3.24%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-38.21%
|
O:
-1.74%
H:
4.84%
C:
3.88%
BEAM
|
$23.9
-1.69%
-1.72%
4.5M
|
Health Technology
|
-43.23%
|
O:
0.21%
H:
4.84%
C:
2.99%
financial
results
LAMEA Attention Deficit Hyperactivity Disorder Market 2022: Sector to Grow by 7.3% Annually Through 2028
Published:
2023-01-18
(Crawled : 12:00)
- prnewswire.com
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
-94.91%
|
O:
-0.13%
H:
3.25%
C:
-3.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
22.87%
|
O:
0.05%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-18.02%
|
O:
0.62%
H:
0.12%
C:
-0.68%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-43.58%
|
O:
-1.16%
H:
0.67%
C:
-1.2%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
2.14%
|
O:
0.93%
H:
0.01%
C:
-1.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-14.19%
|
O:
-0.41%
H:
0.2%
C:
-1.1%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
103.03%
|
O:
-0.4%
H:
0.75%
C:
-1.21%
SUPN
|
$29.43
1.94%
1.9%
360K
|
Health Technology
|
-26.65%
|
O:
0.07%
H:
2.69%
C:
0.32%
market
Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published:
2023-01-16
(Crawled : 14:00)
- prnewswire.com
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
Email alert
Add to watchlist
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
EMMA
|
$0.1138
385.44%
300
|
Professional, Scientific, and T...
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
DHR
|
$235.51
-0.36%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
global
report
growth
market
Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published:
2022-11-21
(Crawled : 16:00)
- prnewswire.com
EMMA
|
$0.1138
385.44%
300
|
Professional, Scientific, and T...
|
-73.4%
|
O:
33.02%
H:
0.0%
C:
-21.11%
ARVL
|
News
|
$0.49
0.37%
2.5M
|
Manufacturing
|
33.97%
|
O:
-5.8%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
10.11%
|
O:
0.74%
H:
0.89%
C:
0.53%
DHR
|
$235.51
-0.36%
0.0%
2.3M
|
Health Technology
|
-9.65%
|
O:
-0.32%
H:
1.21%
C:
0.09%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
3.28%
|
O:
-0.13%
H:
1.13%
C:
0.14%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
4.7%
|
O:
1.02%
H:
0.0%
C:
0.0%
SGMO
|
$0.5143
6.02%
5.68%
1M
|
Health Technology
|
-86.03%
|
O:
-1.1%
H:
1.66%
C:
-0.28%
ALNY
|
$144.315
-0.58%
-0.59%
700K
|
Health Technology
|
-33.56%
|
O:
0.22%
H:
2.19%
C:
-5.13%
global
report
market
Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
Published:
2022-11-14
(Crawled : 13:20)
- biospace.com/
SYRS
|
$4.54
-3.81%
-3.96%
260K
|
Health Technology
|
14.07%
|
O:
-1.76%
H:
2.56%
C:
-6.39%
pharmaceuticals
financial
update
results
Sickle Cell Disease Treatment Market to Garner USD 1.6 Billion by 2031: Allied Market Research
Published:
2022-11-10
(Crawled : 01:00)
- prnewswire.com
EMMA
|
$0.1138
385.44%
300
|
Professional, Scientific, and T...
|
-75.68%
|
O:
-18.92%
H:
15.0%
C:
15.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
13.73%
|
O:
2.81%
H:
0.43%
C:
-0.2%
treatment
research
disease
market
Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook
Published:
2022-11-01
(Crawled : 12:00)
- biospace.com/
HLN
|
$8.22
1.11%
0.0%
3.6M
|
n/a
|
34.31%
|
O:
0.16%
H:
1.79%
C:
0.16%
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
20.89%
|
O:
-1.68%
H:
0.0%
C:
-0.27%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
12.16%
|
O:
7.74%
H:
0.17%
C:
0.17%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-44.15%
|
O:
3.11%
H:
0.88%
C:
0.02%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
19.84%
|
O:
1.72%
H:
0.39%
C:
-0.83%
BHVN
1 d
|
$38.99
-7.52%
0.0%
3.4M
|
Health Technology
|
135.3%
|
O:
1.81%
H:
3.08%
C:
-0.65%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
7.42%
|
O:
0.23%
H:
0.0%
C:
0.0%
BNTX
|
$86.82
0.75%
0.75%
1.6M
|
Health Technology
|
-36.93%
|
O:
4.54%
H:
4.25%
C:
0.13%
BEAM
|
$23.9
-1.69%
-1.72%
4.5M
|
Health Technology
|
-45.76%
|
O:
3.25%
H:
1.41%
C:
-2.48%
ARVN
|
$34.78
1.43%
1.41%
940K
|
Health Technology
|
-30.15%
|
O:
1.49%
H:
3.25%
C:
1.68%
results
Pfizer Completes Acquisition of Global Blood Therapeutics
Published:
2022-10-05
(Crawled : 16:00)
- biospace.com/
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-41.52%
|
O:
-0.76%
H:
0.57%
C:
0.0%
acquisition
blood
global
therapeutics
STOCKHOLDER ALERT: The M&A Class Action Firm Launches Merger Inquiry - RFP, SBTX, GBT, EVOP
Published:
2022-09-24
(Crawled : 20:20)
- prnewswire.com
GPN
|
$122.1
-0.07%
0.0%
1.1M
|
Technology Services
|
Email alert
Add to watchlist
EVOP
4
|
$33.99
0.38%
0.38%
0
|
Commercial Services
|
Email alert
Add to watchlist
RFP
|
$21.92
0.0%
0
|
Process Industries
|
Email alert
Add to watchlist
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
Email alert
Add to watchlist
Folia Health Technology Platform Used in First-of-its-Kind Real World Evidence Study for Sickle Cell Disease
Published:
2022-09-15
(Crawled : 23:00)
- biospace.com/
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
0.78%
|
O:
-0.15%
H:
0.06%
C:
-0.1%
disease
health
technology
study
platform
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Published:
2022-09-15
(Crawled : 23:00)
- globenewswire.com
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
1.03%
|
O:
-0.1%
H:
0.1%
C:
-0.13%
treatment
disease
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
Published:
2022-08-08
(Crawled : 11:00)
- globenewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-47.23%
|
O:
0.24%
H:
0.85%
C:
0.36%
MS
|
News
0 d
|
$90.66
0.44%
0.07%
8.1M
|
Finance
|
5.26%
|
O:
0.73%
H:
0.53%
C:
-0.84%
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
45.18%
|
O:
41.47%
H:
0.0%
C:
0.0%
blood
rare
global
acquire
therapeutics
GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
Published:
2022-07-29
(Crawled : 13:00)
- biospace.com/
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
101.18%
|
O:
-4.73%
H:
1.17%
C:
0.89%
results
MHRA Grants Marketing Authorization for GBT’s Oxbryta® (voxelotor) for Use in Great Britain for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Age 12 Years and Older
Published:
2022-07-26
(Crawled : 08:00)
- globenewswire.com
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
103.81%
|
O:
-0.42%
H:
1.7%
C:
-0.33%
oxbryta
treatment
disease
anemia
grants
authorization
GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil
Published:
2022-07-14
(Crawled : 14:20)
- biospace.com/
GBT
|
$68.49
0.02%
-0.02%
|
Health Technology
|
93.83%
|
O:
-0.65%
H:
0.15%
C:
-1.05%
disease
brazil
program
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.